Your browser doesn't support javascript.
loading
Allostatic load in opioid use disorder: a scoping review protocol.
Fan, Jaimie Qiuyun; Miller, Hillary; Adams, Amanda; Bryan, Rebecca; Salzman, Matthew.
Afiliação
  • Fan JQ; Cooper Medical School of Rowan University, Camden, New Jersey, USA.
  • Miller H; Rutgers School of Nursing, Camden, New Jersey, USA.
  • Adams A; Department of Medical Library, Cooper Medical School of Rowan University, Camden, New Jersey, USA.
  • Bryan R; Rutgers School of Nursing, Camden, New Jersey, USA.
  • Salzman M; Department of Emergency Medicine, Cooper Medical School of Rowan University, Camden, New Jersey, USA Salzman-Matthew@CooperHealth.edu.
BMJ Open ; 13(3): e060522, 2023 03 17.
Article em En | MEDLINE | ID: mdl-36931678
ABSTRACT

INTRODUCTION:

Opioid use disorder affects 2.1 million individuals in the USA, causing more than 100 000 overdose-related deaths annually. While the neurobiological model of addiction is well described and accepted, there is a lack of morbidity and mortality prognosticators for patients struggling with opioid use disorder. Allostatic load index is a promising candidate for the basis of a prognostication tool. Previous studies show that allostatic load predicts both morbidity and mortality in a variety of cohorts. This scoping review protocol provides the rationale and steps for summarising and presenting existing evidence surrounding allostatic load in the context of opioid use disorder. Identification of current knowledge gaps will pave the way for subsequent prospective studies. METHODS AND

ANALYSIS:

This scoping review protocol will follow the five-step method designed by Arksey and O'Malley. All studies written in English on allostatic load in the context of opioid use disorder, as defined in our inclusion criteria, will be included. There will be no limit on the year of publication. We will search PubMed, Embase, CINAHL, PsycINFO and Google Scholar. We will hand-review reference lists of included articles, and we will hand search grey literature. We will then group, analyse and present the data in narrative, tabular and diagrammatic format according to themes identified in the scoping review. ETHICS AND DISSEMINATION Ethics approval is not necessary, as data are gathered from publicly accessible sources. The results will be disseminated through a peer-reviewed journal and reported at conferences related to addiction medicine. TRIAL REGISTRATION NUMBER 10.17605/OSF.IO/4J6DQ.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alostase / Transtornos Relacionados ao Uso de Opioides Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alostase / Transtornos Relacionados ao Uso de Opioides Idioma: En Ano de publicação: 2023 Tipo de documento: Article